Literature DB >> 8483104

Antiproliferative effect of pineal indoles on cultured tumor cell lines.

S F Sze1, T B Ng, W K Liu.   

Abstract

The in vitro antiproliferative action of pineal indoles on several tumor cell lines including melanoma (B16), sarcoma (S180), macrophage-like cell line (PU5), fibroblasts (3T3), and choriocarcinoma (JAr) was examined by measuring the incorporation of 3H-thymidine by the tumor cells, and, in the case of melanoma cells, by also measuring the incorporation of 3H-leucine and 3H-uridine. Uptake of crystal violet was used to assess the viability of the tumor cells. The order of inhibitory potency of the indoles was found to be methoxytryptamine > melatonin, methoxytryptophol, hydroxytryptophol, and methoxyindoleacetic acid > serotonin and hydroxyindoleacetic acid. The possibility of an adverse effect of the indoles on the viability of normal cells was also investigated by employing a primary culture of rat hepatocytes. The release of glutamate-oxaloacetate transaminase by hepatocytes was not affected by the indoles, although the release of glutamate-pyruvate transaminase was increased to a small extent and the uptake of crystal violet was slightly inhibited.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483104     DOI: 10.1111/j.1600-079x.1993.tb00481.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  6 in total

1.  Development of pre-implantation mouse embryos under the influence of pineal indoles.

Authors:  W Y Chan; T B Ng
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients.

Authors:  Giuseppina Messina; Paolo Lissoni; Paolo Marchiori; Erio Bartolacelli; Fernando Brivio; Luciano Magotti
Journal:  J Res Med Sci       Date:  2010-07       Impact factor: 1.852

3.  Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.

Authors:  V Martín; A M Sanchez-Sanchez; F Herrera; C Gomez-Manzano; J Fueyo; M A Alvarez-Vega; I Antolín; C Rodriguez
Journal:  Br J Cancer       Date:  2013-04-30       Impact factor: 7.640

Review 4.  Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?

Authors:  E S Schernhammer; K Schulmeister
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

Review 5.  The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results.

Authors:  Paolo Lissoni; Giusy Messina; Arianna Lissoni; Rovelli Franco
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

6.  Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.

Authors:  Ana B Cerezo; Ruth Hornedo-Ortega; M Antonia Álvarez-Fernández; Ana M Troncoso; M Carmen García-Parrilla
Journal:  Nutrients       Date:  2017-03-08       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.